Article Sidebar

Download
PDF

Main Article Content

Abstract

RÉSUMÉ
Le phéochromocytome ou chromaffinome est une tumeur rare qui se développe dans la médullosurrénale. Il secrète presque toujours des catécholamines dont la principale manifestation remarquable est l'hypertension artérielle. Nous rapportons la première observation d’un phéochromocytome à l’Hôpital Préfectoral de Siguiri (République de Guinée), une formation sanitaire située à plus de 700 km de la capitale du pays et la discutons à la lumière des données de la littérature.


ABSTRACT
Pheochromocytoma or chromaffinoma is a rare tumour that develops in the adrenal medulla. It almost always secretes catecholamines the main clinical consequence of which is arterial hypertension. The annual incidence of these tumours is 1 to 4 per million inhabitants. It mainly affects boys whose average age at the time of discovery is 10 years. The final diagnosis is usually made by histopathology after surgical extraction. In Guinea, to our knowledge, no case has been reported in the literature, hence the subject of this observation.

Keywords

Pheochrocytoma High blood pressure Prefectural Hospital of Siguiri Phéochrocytome Hypertension artérielle Hôpital préfectoral de Siguiri

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite
Camara T, Traore A, Diallo Ay, Sylla D, Kake A, Diabate L, & Kaba Ml. (2023). Phéochromocytome Juvénile à l’Hôpital Préfectoral de Siguiri (Guinée) : A Propos d’un Cas. HEALTH SCIENCES AND DISEASE, 25(1). https://doi.org/10.5281/hsd.v25i1.5147
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Doyon S : Un cas de phéochromocytome. Pharmactuel 2006 ; 39,5 :268672.
  2. Ilias I, Pacak K. Current Approaches and Recommended Algorithm for the Diagnostic Localisation of Pheochromocytoma Clin Endocrinol Metab 2004;89:479-91.
  3. Pisoni R ,Ahmed MI, Calhoun DA. "Characterization and Treatment of Resistant Hypertension" Curr. Cardiol Resp 2009;11:407-13.
  4. Graham JB. Pheochromocytoma and hypertension: An analysis of 207 cases. Int. Abstracts surg. 1951; 92(2): 105-21. Pub. Med.
  5. Dubois R, Chappuis JP. Le phéochromocytome : particularités pédiatriques.Arch Pediatr 1997 ; 4 :1217-25.
  6. Ross JH. Pheochromocytoma. Special Considerations in Children. Urol Clin North Am 2000, 27 :393-402.
  7. Legmann P. Conduite à tenir devant un incidentalome surrénalien : scanner –IRM. Journal de Radiologie Volume 90, Issue 3, Part 2, March 2009, pages 426-441.
  8. Bessell- Browne R, O’Malley ME. CT of pheochromo-cytoma and paraganglioma : risk of adverse events with i.v. administration of nonionic contrast material .AJR Am.J.Roentgenol.2007 Apr ; 188(4) :970-4.
  9. Dalal T, Maher MM, Kalra MK, Mueller PR .Extraa-drenalpheochromocytoma : a rare cause of tachycardia and hypertension during percutaneous biopsy .AJR Am J Roentgenol.2005Aug ; 185(2) :554-5.
  10. Taieb D, Tessonnier L, Mundler O. Imagerie molécu-laire nucléaire des paragangliomes médecine Nucléaire, Volume 34, issue 8, August 2010, pages 451-456.
  11. Young W. Endocrine hypertension: Pheochromocytoma and primary, Aldosteronism.2005 :631-45.
  12. Lenders J, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma Lancet 2005;366:665-75.
  13. Kinney MAO, Narr BJ, Warner MA. Periperative Management of Pheochromocytoma. J Cardiothorac Vasc Anesth 2002 :16 :359-69.2009; 30(5): 307-312. doi: 10.5405/jmbe.30.5.06.

Most read articles by the same author(s)